John C. Thomas - Jun 23, 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
Director
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
VIRI
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/30/2022, 02:01 PM
Previous filing
Jan 4, 2022
Next filing
Jun 20, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +5.25K $0.00 5.25K Jun 23, 2022 Common Stock 5.25K $4.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on June 23, 2023, one year following the grant date.